Professional Documents
Culture Documents
Aims
To provide accurate information about: the presence or absence of microorganisms, or characterized biomarker of microorganism in a specimen that may be involved in patients disease process
Important requirements
Adequate collection, transport, and processing of clinical specimens Cooperation among medical team members :
Clinical practitioners Nurses Laboratory practitioners
Diagnostic Microbiology:
Culture Assays for Bacteria and Fungi Culture Assays for virus
Hari ke 1
Spesimen
Diterima
Ditolak
Mikroskopik
Hari ke 2
Isolat
Uji biokimiawi
Uji serologi
Hari ke 3
Identitas bakteri
Bacteremia
Specimens that have sat too long prior to processing must be rejected Select venipuncture site. Avoid the femoral vein area.
Blood volume
Adults : <30 CFU/ml, more blood that is cultured, the greater the chance of isolating the organism Children : <5 CFU/ml, infants : >1000 CFU/ml
Effect of Volume
100 90 80 70 60 % Relative 50 Yield 40 30 20 10 0 5 10 15 20 25 30 35
ml
*Reprinted from Infectious Disease Clinics of North America, Vol 16, M.L. Towns and L. B. Reller, Diagnostics methods: Current best practices and guidelines for isolation of bacteria and fungi in infective endocarditis, p. 363376(2002) with permission from Elsevier.
40 45
50
55 60
Subculture
5% sheep blood agar Mc Conkey / Endo agar Chocolate agar Supplemented anaerobic blood agar
Further identification
Ability to produce enzymes that can be detected by simple tests Ability to metabolize sugars oxidatively or fermentatively Ability to use a range of substrates for growth Some species are identified on the basis of their antigens by reacting cell suspensions with specific antisera
Fungi
Identified from colonial characteristics and cell morphology Biochemical tests (substrates assimilation) Grow more slowly than bacteria and final identification may take up to 2 weeks
KULTUR DARAH
GRAM
AEROB
AD
MAC
AC
GRAM
ANAEROB
GRAM
IDENTIFIKASI
KONVENSIONAL API 20 E API 20 NE API STREP API 20 A (ANAEROB) API CAUX (JAMUR)
UJI KEPEKAAN
Antibiotic susceptibility
Methods that are directly measure the activity of one or more antimicrobial agents against a bacterial isolates
Methods that are directly detect the presence of a specific resistance mechanism in a bacterial isolate
Special methods that are measure complex antimicrobial-organism interactions
Blood Agar
Dilusion Test
no zone around disc = resistant
8mg/ L
4mg/ L
2mg/ L
1mg/ L
0.5m g/L
0.25 mg/L
cloudiness means bacteria can grow at amount of that concentration of antibiotic antibiotic MIC=2mg/L
E-Test
Plant and animal viruses can be grown in laboratory plants and animals Plant: tobacco ((tobacco mozaic viruses) Animals: rats, mice, guinea pigs, rabbits, pigs, primates
Plaque assay
http://www.nanohedron.com
Serologic Methods
Agglutination assays Precipitation assays Complement fixation test Neutralization test Microscope-assisted labeled-reagent technique Immunoassays with labeled reagents (EIA, RIA, FIA)
Antigen detection
Microbial-specific structural components (antigens) are identified in specimens obtained from an infected host Can be used to identify microorganisms once they have been recovered in culture Methods depends on the fact that some microbial components are chemically unique and form areas on the molecule known as antigenic determinants The antigens can be recognized or bond by specifically with antibody molecules to form stable products
Antibody detection
IgM antibodies
detected earlier in the infection (7-10 days) Usually indicative of active, as opposed to past, infection
IgG antibodies
Previous infections or immunization Serodiagnosis of an infectious diseases requires measurement of IgG concentration on both acute-phase and convalescent-phase serum specimens Chronic infections, epidemiology
Neonates may not always respond to an infectious agent because their immune system are not fully mature For some infections (e.g. legionaires disease) antibody titers may not rise until months after acute infection
Reactivation of a latent organism due to infection by a different organism Receiving intravenous immunoglobulin
Agglutination
Hemaglutinasi
Aglutinasi dengan sel darah merah
HEMAGLUTINASI
AGLUTINASI SEL DARAH MERAH DAPAT TERJADI :
SDM
SDM
ANTIGEN
ANTIBODI
SDM
SDM
HEMAGLUTINASI
2. VIRUS / RICKETTSIA
SDM
SDM
SDM
HAMBATAN HEMAGLUTINASI
VIRUS + ANTIBODI
Hemaglutinasi
SDM
SDM
SDM
SDM
+
SDM SDM SDM SDM
ANTIGEN
HEMAGLUTINASI
1/160
1/320 1/640 1/1280 1/2560
Titer Antigen : 1/160 (1 HAU ) Untuk Reaksi HI digunakan Antigen 4 8 HAU
1/20
1/40
1/80 1/160 1/320 1/640 1/1280 1/2560
Bila jarak pengambilan serum fase akut dan serum konvalesens 8 hari, maka Interpretasi hasil pemeriksaan ini adalah: Definitif infeksi dengue, sekunder
TABEL INI TIDAK USAH DIHAFAL, CUKUP DILATIH PENGGUNAANNYA, AGAR DAPAT CEPAT MENGINTERPRETASI DALAM UJIAN
1/8
1/16 1/32 1/64 1/128 1/256
Titer virus : 64 (1 unit) Untuk reaksi hambatan-hemaglutinasi virus yang digunakan 4 8 unit 8 x 1/64 = 8/64 = 1/8
KESIMPULAN : Titer antibodi serum I = 40 serum II = 640 Kenaikan titer > 4x infeksi
Kontrol eritrosit
Kontrol antigen
1/320
1/640 1/1280 1/2560
Serum yang diperiksa hanyalah serum fase akut, maka hasil pemeriksaan ini: Tidak bisa diinterpretasi
Ag
Antibodi
Anti SDM
SDM
SISTIM HEMOLISA
Tahap 2: tambahkan sel darah merah dan antibodinya (sensitized cells): indikator adanya komplemen bebas di dalam larutan
1/1280
1/2560
Keterangan :
= tidak lisis
= lisis
Seperti halnya pemeriksaan serologi lainnya, penilaian kenaikan titer serum fase akut dan fase konvalesens yang dianggap positif ialah kenaikan titer sebanyak 4 kali
Kontrol eritrosit diperlukan untuk memastikan bahwa eritrosit tidak mengalami autolisis (lisis dengan sendirinya, tanpa adanya reaksi lisis oleh komplemen). Kontrol lisis diperlukan untuk menilai fungsi antibodi terhadap eritrosit dan komplemen dalam melisis eritrosit.
Bila tidak ada kontrol eritrosit dan kontrol lisis, dapat terjadi kesulitan dalam penilaian hasil uji fiksasi komplemen, khususnya bila semua sumur pada pelat uji fiksasi komplemen menunjukkan gambaran yang sama (lisis semua atau tidak lisis semua)
ELISA
- Deteksi antibodi (IgM atau IgG): IgG: - Disebut positif terinfeksi bila terjadi peningkatan titer antibodi sebanyak 4 kali IgM: - Interpretasi sama dengan IgM blot
- Deteksi antigen - Hasil dinyatakan positif bila nilainya diatas nilai ambang (cut-off value)
Example:
Detection Dengue NS1 Antigen
A. Neg Control 0.104 B. Pos Control 1.234 C. Calibrator D. Calibrator E. Calibrator F. Sample A G. Sample B H. Sample C 0.802 0.800 0.804 0.949 0.070 0.098
A B C D E F G H
Perhitungan: Rata-rata Calibrator = 0.802 Calibration factor = 0.62 Cutt-off value = 0.802 x 0.62 = 0.497 Panbio units = Index value x 10
Index value = Sample absorbance Cut-off value Sample A = 0.949/0.497 x 10 = 19.1 Sample B = 0.070/0.497 x 10 = 1.4 Sample C = 0.098/0.497 X 10 = 1.97
1
Tidak diencerkan A
4
Serum II
8
Serum II
OD:1230
OD:1100
OD:1067
B
OD:1191 OD:335 Serum I OD:1050 Serum I
C
OD:1067
D
OD:821
Pasien I : Serum II diambil 7 hari setelah Pengambilan serum I. Perubahan titer Antibodi dari Serum I ke Serum II ialah: Kenaikan 8X (1/4:1/32)
Pasien II : Serum II diambil 7 hari setelah pengambilan Serum I Perubahan titer Antibodi dari Serum I ke Serum II ialah : 1 X (tidak ada perubahan)
1/16 E
OD:751
1/32 F
OD:335
1/64 G
OD:233
1/128 H
OD:128
Nilai Standar
Arti kenaikan Titer ini ialah: Pasien tidak dalam infeksi akut
Immunoperoxide Assay
+
Substrat (DAB + H2O2)
Antigen Products Available Antigen Salmonella O, Group A, B, C, D Antigen Salmonella H, Group A, B, C, D The reagents used in this practical laboratory contain 0.1% sodium azide as a preservative which may be toxic if ingested and the antigens are preserved with 0.5% Formalin
Titer
S. paratyphi A (Grup A) S. paratyphi B (Grup B) S. paratyphi C (Grup C) S. typhi (Grup D) Kontrol Serum +/-
1:40
1:80
1:160
1:320
1:40
1:80
1:160
1:320
(-)
(+)
(-)
(+)
!
Secondary Dengue Infection: IgM : visible band IgG : visible band Control: visible band
Suspected secondary Dengue Infection : IgM : No band IgG : visible band Control: visible band
This result may be due to infection by other members of flavivirus: - Japanese encephalitis - Chikungunja - Ross River Virus - Yellow Fever virus
Interpretation
Primary infection: serum IgM antibodies can be detected from dengue patients as early as 3-5 days after the onset of fever, generally persisting for 30-90 days Secondary infection: characterized by high IgG levels that may or may not be accompanied by elevated IgM levels The sensitivity of this assay has been set: primary dengue: IgM is positive while IgG is negative secondary infections: a positive IgG result with or without a positive IgM result. Serological cross-reactivity across the flavivirus group is common.
Molecular Assays
Hybridization of a characterized nucleic acid probe to a specific nucleic acid sequence in a test specimen followed by detection the paired hybrid Nucleic acid probe typically is labelled with enzymes, antigenic substrates, chemiluminescent molecules, or radioistopes to facilitate detection of the hybridization product
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) untuk Diagnosis Infeksi Virus Dengue
Tujuan : - Deteksi RNA virus dengue - Penentuan tipe virus Sampel : Serum/ plasma pada masa akut (hari demam 1 4) Metoda : - Isolasi RNA - RT-PCR : RT-PCR dilakukan berdasarkan metoda Lanciotti, yang terdiri dari 2 tahap, yaitu tahap pertama, RT diikuti PCR menggunakan primer universal, dilanjutkan dengan semi nested PCR menggunakan primer yang spesifik tipe, seperti dapat dilihat pada gambar 1 dan tabel 1. - Elektroforesis pada gel agarosa 2%, Hasil yang diharapkan : Kontrol positif : (+) Kontrol negatif; isolasi RNA (-); kontrol negatif reagen : (-) DEN-1 = 482 bp DEN-3 = 290 bp DEN-2 = 119 bp DEN-4 = 392 bp
Primer Sekuens Nukleotida Posisi Genom 134-161 616-644 568-586 232-252 400-421 506-527 Ukuran Produk (bp) 511 511 482 119 290 392
Hasil elektroforesis produk RT-PCR Dengue (M) marker Phi X 174 DNA/Hae III; (1) DEN-1 = 482 bp; (2) DEN-3 = 290 bp; (3) DEN-2 = 119 bp; (4) DEN-4 = 392 bp; (5) Kontrol isolasi RNA; (6) Kontrol negatif PCR; (7) Kontrol positif PCR.
Result of Duplex PCR Assay for Detection of Haemophilus influenzae and Moraxella catarrhalis
bp
S kM k+
Hi (525 bp)
Mc (237 bp)
bp: base pair. S: sample. k-: Negative control. M: DNA Ladder. k+: Positive control. Hi: Haemophilus influenzae Mc: Moraxella catarrhalis.
Result of Multiplex PCR Assay for Detection of Candida Glabrata, C. parapsilosis, C. tropicalis, C. krusei and C. Albicans bp
M k+ k-
500
Cg (483 bp)
bp: base pair. M: DNA Ladder. k+: Positive control. k-: Negative control. Cg: Candida Glabrata.Cp: C. parapsilosis. Ct: C. Tropicalis. Ck: C. krusei. Ca: C. Albicans.
Viral Load
1. Menetapkan diagnosis
2. Memutuskan dimulai atau dihentikannya terapi 3. Mengganti komposisi obat-obat anti retrovirus
(VIRAL LOAD)
Dimensi Baru:
- Penanganan penyakit - Prognosis - Strategi pengobatan
Load
INFEKSI HIV
FAKTOR-FAKTOR PEJAMU
VIRAL LOAD
HIV-1 Genotyping
HIV-1 Genotyping
The HIV-1 Genotyping System is used for identifying mutations in the pol gene of the human immunodeficiency virus, type one (HIV-1). The entire Protease gene and approximately two thirds of the Reverse Transcriptase (RT) gene in the pol open reading frame are amplified (approximately 1.8 kilobases (kb). The amplicon is subsequently used as a sequencing template to generate approximately 1.2kb of sequence data. Genotypic analysis of the region of HIV-1 facilitates the study of the relationship between mutations and viral resistance to anti-retroviral drugs, specifically the protease and RT inhibitors. The sequencing data are then used to provide supplemental information regarding the potential HIV-1 susceptibility to current anti-retroviral drugs. Physicians use the data in conjunction with patient clinical data to make treatment decisions.
HIV-1 Genotyping
Polymerase Chain Reaction (PCR)
Sequencing Reaction
TRANSFER TO NITROCELLULOSE
NITROCELLULOSE
4. WESTERN BLOT
Serum pasien +
gp160 gp120 p66 p55 p51 gp41 p31 p24 Indeterminate p17 p24, gp41, p55, p66, gp120, gp160 Indeterminate p24, p55, gp160
Interpretation
band present
Indeterminate
p24, p55
Positive
Serum control HIV-2